|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Johnston PA and Grandis JR: STAT3
signaling: Anticancer strategies and challenges. Mol Interv.
11:18–26. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Song Y, Qian L, Song S, Chen L, Zhang Y,
Yuan G, Zhang H, Xia Q, Hu M, Yu M, et al: Fra-1 and Stat3
synergistically regulate activation of human MMP-9 gene. Mol
Immunol. 45:137–143. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Xie TX, Wei D, Liu M, Gao AC, Ali-Osman F,
Sawaya R and Huang S: Stat3 activation regulates the expression of
matrix metalloproteinase-2 and tumor invasion and metastasis.
Oncogene. 23:3550–3560. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cheng GZ, Zhang WZ, Sun M, Wang Q, Coppola
D, Mansour M, Xu LM, Costanzo C, Cheng JQ and Wang LH: Twist is
transcriptionally induced by activation of STAT3 and mediates STAT3
oncogenic function. J Biol Chem. 283:14665–14673. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Niu G, Wright KL, Huang M, Song L, Haura
E, Turkson J, Zhang S, Wang T, Sinibaldi D, Coppola D, et al:
Constitutive Stat3 activity up-regulates VEGF expression and tumor
angiogenesis. Oncogene. 21:2000–2008. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wei D, Le X, Zheng L, Wang L, Frey JA, Gao
AC, Peng Z, Huang S, Xiong HQ, Abbruzzese JL and Xie K: Stat3
activation regulates the expression of vascular endothelial growth
factor and human pancreatic cancer angiogenesis and metastasis.
Oncogene. 22:319–329. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xu Q, Briggs J, Park S, Niu G, Kortylewski
M, Zhang S, Gritsko T, Turkson J, Kay H, Semenza GL, et al:
Targeting Stat3 blocks both HIF-1 and VEGF expression induced by
multiple oncogenic growth signaling pathways. Oncogene.
24:5552–5560. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yahata Y, Shirakata Y, Tokumaru S,
Yamasaki K, Sayama K, Hanakawa Y, Detmar M and Hashimoto K: Nuclear
translocation of phosphorylated STAT3 is essential for vascular
endothelial growth factor-induced human dermal microvascular
endothelial cell migration and tube formation. J Biol Chem.
278:40026–40031. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yu H, Kortylewski M and Pardoll D:
Crosstalk between cancer and immune cells: Role of STAT3 in the
tumour microenvironment. Nat Rev Immunol. 7:41–51. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yu XT, Zhu SN, Xu ZD, Hu XQ, Zhu TF, Chen
JQ and Lu SL: Roles of EGFR-Stat3 signal pathway in carcinogenesis
of experimental hepatoma in rats. J Cancer Res Clin Oncol.
133:145–152. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shuai K: Regulation of cytokine signaling
pathways by PIAS proteins. Cell Res. 16:196–202. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Croker BA, Kiu H and Nicholson SE: SOCS
regulation of the JAK/STAT signalling pathway. Semin Cell Dev Biol.
19:414–422. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Masciocchi D, Gelain A, Villa S,
Meneghetti F and Barlocco D: Signal transducer and activator of
transcription 3 (STAT3): A promising target for anticancer therapy.
Future Med Chem. 3:567–597. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gong L, Wu Z, Guo L, Li L, Zhao R, Zhu D
and Zhou Q: Metastasis suppressor Nm23-H1 inhibits STAT3 signaling
via a negative feedback mechanism. Biochem Biophys Res Commun.
434:541–546. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Steeg PS, Bevilacqua G, Pozzatti R, Liotta
LA and Sobel ME: Altered expression of NM23, a gene associated with
low tumor metastatic potential, during adenovirus 2 Ela inhibition
of experimental metastasis. Cancer Res. 48:6550–6554.
1988.PubMed/NCBI
|
|
17
|
Hartsough MT and Steeg PS: Nm23/nucleoside
diphosphate kinase in human cancers. J Bioenerg Biomembr.
32:301–308. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Steeg PS, Palmieri D, Ouatas T and Salerno
M: Histidine kinases and histidine phosphorylated proteins in
mammalian cell biology, signal transduction and cancer. Cancer
Lett. 190:1–12. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lu Z, Guo L, Li L, Wu Z and Zhou Q:
Construction and expression of nm23-H1 gene with different enzyme
activities and resistant specific shRNA in eukaryotic expression
vector. Zhongguo Fei Ai Za Zhi. 17:183–188. 2014.(In Chinese).
PubMed/NCBI
|
|
20
|
Guo L, Li L, Wang W, Pan Z, Zhou Q and Wu
Z: Mitochondrial reactive oxygen species mediates nicotine-induced
hypoxia-inducible factor-1α expression in human non-small cell lung
cancer cells. Biochim Biophys Acta. 1822:852–861. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xie TX, Huang FJ, Aldape KD, Kang SH, Liu
M, Gershenwald JE, Xie K, Sawaya R and Huang S: Activation of Stat3
in human melanoma promotes brain metastasis. Cancer Res.
66:3188–3196. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
MacDonald NJ, De la Rosa A, Benedict MA,
Freije JM, Krutsch H and Steeg PS: A serine phosphorylation of
Nm23, and not its nucleoside diphosphate kinase activity,
correlates with suppression of tumor metastatic potential. J Biol
Chem. 268:25780–25789. 1993.PubMed/NCBI
|
|
23
|
Otsuki Y, Tanaka M, Yoshii S, Kawazoe N,
Nakaya K and Sugimura H: Tumor metastasis suppressor nm23H1
regulates Rac1 GTPase by interaction with Tiam1. Proc Natl Acad Sci
USA. 98:pp. 4385–4390. 2001; View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Auzenne EJ, Klostergaard J, Mandal PK,
Liao WS, Lu Z, Gao F, Bast RC Jr, Robertson FM and McMurray JS: A
phosphopeptide mimetic prodrug targeting the SH2 domain of STAT3
inhibits tumor growth and angiogenesis. J Exp Ther Oncol.
10:155–162. 2012.PubMed/NCBI
|
|
25
|
Mandal PK, Gao F, Lu Z, Ren Z, Ramesh R,
Birtwistle JS, Kaluarachchi KK, Chen X, Bast RC Jr, Liao WS and
McMurray JS: Potent and selective phosphopeptide mimetic prodrugs
targeted to the Src homology 2 (SH2) domain of signal transducer
and activator of transcription 3. J Med Chem. 54:3549–5463. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Siveen KS, Sikka S, Surana R, Dai X, Zhang
J, Kumar AP, Tan BK, Sethi G and Bishayee A: Targeting the STAT3
signaling pathway in cancer: Role of synthetic and natural
inhibitors. Biochim Biophys Acta. 1845:136–154. 2014.PubMed/NCBI
|
|
27
|
Dabir S, Kluge A, McColl K, Liu Y, Lam M,
Halmos B, Wildey G and Dowlati A: PIAS3 activates the intrinsic
apoptotic pathway in non-small cell lung cancer cells independent
of p53 status. Int J Cancer. 134:1045–1054. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Abbas R, McColl KS, Kresak A, Yang M, Chen
Y, Fu P, Wildey G and Dowlati A: PIAS3 expression in squamous cell
lung cancer is low and predicts overall survival. Cancer Med.
4:325–332. 2015. View
Article : Google Scholar : PubMed/NCBI
|
